MedPath

Craig Rush

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:6

Trial Phases

3 Phases

Early Phase 1:2
Phase 1:3
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (50.0%)
Early Phase 1
2 (33.3%)
Not Applicable
1 (16.7%)

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

Phase 1
Completed
Conditions
Methamphetamine Use Disorder
Interventions
First Posted Date
2019-11-26
Last Posted Date
2023-01-09
Lead Sponsor
Craig Rush
Target Recruit Count
8
Registration Number
NCT04178993
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

🇺🇸

University of Kentucky Medical Center, Lexington, Kentucky, United States

Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)

Phase 1
Completed
Conditions
Alcohol Use Disorder
Interventions
Drug: Duloxetine (60 MG)
Drug: Duloxetine (30 MG)
Drug: Placebos
First Posted Date
2018-07-02
Last Posted Date
2025-04-10
Lead Sponsor
Craig Rush
Target Recruit Count
19
Registration Number
NCT03575403
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

Behavioral Effects of Drugs: Inpatient (35)

Early Phase 1
Completed
Conditions
Cocaine Use Disorder
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-08
Last Posted Date
2019-06-25
Lead Sponsor
Craig Rush
Target Recruit Count
9
Registration Number
NCT03519022
Locations
🇺🇸

University of Kentucky Medical Center, Lexington, Kentucky, United States

Brief Online Interventions for Alcohol Use

Not Applicable
Completed
Conditions
Alcohol Use Disorder
First Posted Date
2018-02-19
Last Posted Date
2020-01-29
Lead Sponsor
Craig Rush
Target Recruit Count
444
Registration Number
NCT03438539
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence

Early Phase 1
Completed
Conditions
Cocaine Use Disorders
Interventions
First Posted Date
2012-12-03
Last Posted Date
2018-06-26
Lead Sponsor
Craig Rush
Target Recruit Count
34
Registration Number
NCT01739192
Locations
🇺🇸

University of Kentucky Medical Center, Lexington, Kentucky, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.